TAT 2019 - International Congress on Targeted Anticancer Therapies is organized by European Society for Medical Oncology (ESMO) and will be held from Feb 25 - 27, 2019 at Paris Convention Center, Paris, Ile-de-France, France.
This conference is the premier forum for discussion of early phase drug development and translational research. This conference series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.
Leaders from academia and industry, clinicians, researchers and regulators work together to speed up the development of new anti-cancer treatments for better patient outcomes.
Additional details will be posted as soon as they are available.
|Contact No.||:||+41 (0)91 973 19 62|
|Registration Type||Due Date||Price|
|Industry delegates Late Fee||06 Feb,2019||EUR 978.00|
|Industry delegates Conference Fee||24 Feb,2019||EUR 1080.00|
|Non-members academic /non-profit Late Fee||06 Feb,2019||EUR 732.00|
|Non-members academic /non-profit Conference Fee||24 Feb,2019||EUR 828.00|
|Non-members in training Late Fee||06 Feb,2019||EUR 312.00|
|Non-members in training Conference Fee||24 Feb,2019||EUR 432.00|
|ESMO Members Late Fee||06 Feb,2019||EUR 492.00|
|ESMO Members Conference Fee||24 Feb,2019||EUR 564.00|
|ESMO Members in training Late Fee||06 Feb,2019||EUR 210.00|
|ESMO Members in training Conference Fee||24 Feb,2019||EUR 294.00|
|Small Biotech delegates Late Fee||06 Feb,2019||EUR 732.00|
|Small Biotech delegates Conference Fee||24 Feb,2019||EUR 732.00|
|Registration Type||End Date||Price|
|Industry delegates Early Fee||19 Dec,2018||EUR 876.00|
|Non-members academic /non-profit Early Fee||19 Dec,2018||EUR 630.00|
|Non-members in training Early Fee||19 Dec,2018||EUR 312.00|
|ESMO Members Early Fee||19 Dec,2018||EUR 420.00|
|ESMO Members in training Early Fee||19 Dec,2018||EUR 210.00|
|Small Biotech delegates Early Fee||19 Dec,2018||EUR 732.00|